Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention

被引:1
|
作者
Manuck, Tracy A. [1 ,2 ,3 ,4 ]
Watkins, Scott [2 ]
Esplin, M. Sean [2 ,3 ,4 ]
Parry, Samuel [4 ,5 ]
Zhang, Heping [4 ,6 ]
Huang, Hao [4 ,6 ]
Biggio, Joseph R. [4 ,7 ]
Bukowski, Radek [4 ,6 ]
Saade, George [4 ,8 ]
Andrews, William [4 ,7 ]
Baldwin, Don [4 ,5 ]
Sadovsky, Yoel [4 ,9 ]
Reddy, Uma [4 ,10 ]
Ilekis, John [4 ,10 ]
Varner, Michael W. [2 ,3 ,4 ]
Yandell, Mark [2 ]
Jorde, Lynn B. [2 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Intermt Healthcare, Salt Lake City, UT USA
[4] Genom & Prote Network Preterm Birth Res GPN, Bethesda, MD USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Yale Univ, New Haven, CT USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Texas Med Branch, Galveston, TX 77555 USA
[9] Univ Pittsburgh, Pittsburgh, PA USA
[10] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
关键词
D O I
10.1016/j.ajog.2015.10.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
12
引用
收藏
页码:S9 / S10
页数:2
相关论文
共 50 条
  • [41] Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate
    Co, Aila L.
    Walker, Hetty C.
    Hade, Erinn M.
    Iams, Jay D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (02) : 233.e1 - 233.e5
  • [42] 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth: One Size May Not Fit All
    Heyborne, Kent D.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (04): : 899 - 903
  • [43] Progesterone (17α-Hydroxyprogesterone Caproate) for Prevention of Preterm Birth and Preeclampsia
    Ngai, Ivan
    Sheen, Jean-Ju
    Garretto, Diana
    Govindappagari, Shravya
    Bernstein, Peter
    Garry, David J.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 162S - 162S
  • [44] 17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth
    Ntozini, Robert
    Prendergast, Andrew J.
    LANCET HIV, 2021, 8 (10): : E600 - E601
  • [45] Factors Associated with Utilization of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth
    DeNoble, Anna E.
    Wynn, Clara E.
    Weaver, Kristin E.
    Wheeler, Sarahn M.
    Swamy, Geeta K.
    AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (03) : 264 - 270
  • [46] Smoking, 17 Alpha-Hydroxyprogesterone Caproate, and Preterm Birth
    Heyborne, Kent D.
    Allshouse, Amanda A.
    AMERICAN JOURNAL OF PERINATOLOGY, 2016, 33 (12) : 1191 - 1197
  • [47] What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention
    Manuck, Tracy A.
    Gyamfi-Bannerman, Cynthia
    Saade, George
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2023, 5 (10)
  • [49] Conformity with treatment standards and pregnancy outcomes in patients receiving 17 alpha-hydroxyprogesterone caproate (17p) for preterm birth prophylaxis
    Istwan, Niki
    Rhea, Debbie
    Desch, Cheryl
    Stanziano, Gary
    Gonzalez-Quintero, Victor Hugo
    Tudela, Felipe Jose
    Romary, Leticia Maria
    Cordova, Yvette C.
    Achille, Fabienne
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S81 - S81
  • [50] Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate
    Fukuda, Toma
    Kyozuka, Hyo
    Murata, Tsuyoshi
    Yasuda, Shun
    Yamaguchi, Akiko
    Fujimori, Keiya
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (09) : 3119 - 3126